Monday, 27 September 2021

ZOLGENSMA: WORLD’S MOST EXPENSIVE DRUG OF CHOICE; SURVIVAL OF MOTOR FUNCTION FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY TYPE 1

ZOLGENSMA: WORLD’S MOST EXPENSIVE DRUG OF CHOICE; SURVIVAL OF MOTOR FUNCTION FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY TYPE 1
ZOLGENSMA: WORLD’S MOST EXPENSIVE DRUG OF CHOICE; SURVIVAL OF MOTOR FUNCTION FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY TYPE 1

ABOUT AUTHORS
1Dr. Dhananjoy Saha, 2Kushal Nandi, 2Amrita Chakraborty and 2Dr. Dhrubo Jyoti Sen
1Deputy Director, Directorate of Technical Education, Bikash Bhavan, Salt Lake City, Kolkata‒700091, West Bengal, India.
2Department of Pharmaceutics & Pharmaceutical Chemistry, School of Pharmacy, Techno India University, Salt Lake City, Sector‒V, EM‒4, Kolkata‒700091, West Bengal, India.
Email: dhrubosen69@yahoo.com

admin Mon, 09/27/2021 - 16:12
Tags


source https://www.pharmatutor.org/articles/zolgensma-worlds-most-expensive-drug-of-choice-survival-of-motor-function-for-the-treatment-of-spinal-muscular-atrophy-type-1

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...